CreditReports.dk
HomeScreen companies

FAABORG PHARMA A/S Financials, key figures and credit report

CVR number: 26190770 Established 2001 Industry: 20 Manufacture of chemicals and chemical products
Company contact details
Markedspladsen 13 A, 5600 Faaborg info@faaborgpharma.dk tel: 62613100 www.faaborgpharma.dk
Gross profit 13 336.3 kDKK FY 2025 +22.6% vs 2024
EBIT 4 744.4 kDKK FY 2025 +87.2% vs 2024
Net debt 2 480.0 kDKK FY 2025 -67.7% vs 2024
Quick ratio 1.1 FY 2025 +0.2 vs 2024

Income statement (kDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales
Gross profit6 980.0010 327.5110 602.4110 879.5613 336.31
Employee benefit expenses-5 760.00-7 057.34-7 211.63-7 385.14-7 722.74
Other operating expenses- 103.00
Total depreciation- 890.00-1 085.46-1 058.76- 959.44- 869.21
EBIT227.002 184.712 332.022 534.984 744.36
Other financial income4.001.5331.0599.07145.62
Other financial expenses- 194.00- 166.06- 328.64- 390.27-3 138.17
Pre-tax profit37.002 020.182 034.432 243.781 751.81
Income taxes-6.00- 461.30- 423.78- 480.95-1 004.77
Net earnings31.001 558.891 610.651 762.83747.03

Assets (kDKK)

2021
2022
2023
2024
2025
Development expenditure307.00201.91100.95
Intangible rights55.6753.0719.50
Goodwill131.00
Intangible assets total438.00257.58154.0219.50
Buildings1 671.001 468.811 266.691 072.68878.68
Machinery and equipment3 387.005 443.404 748.824 374.643 791.93
Advance payments and construction in progress620.00
Tangible assets total5 678.006 912.216 015.515 447.334 670.61
Holdings in group member companies0.090.090.090.09
Investments total32.0032.02118.62125.74124.20
Long term receivables total
Raw materials and consumables1 443.003 463.123 207.194 061.343 245.78
Finished products/goods3 382.002 929.442 930.712 959.463 067.78
Inventories total4 825.006 392.556 137.917 020.806 313.55
Current trade debtors2 626.003 121.933 123.624 619.704 603.86
Current amounts owed by group member comp.454.001 104.972 218.665 167.462 849.15
Prepayments and accrued income354.00320.05381.46415.90305.39
Current other receivables154.00175.30101.857.007.00
Current deferred tax assets93.00
Short term receivables total3 681.004 722.255 825.5810 210.057 765.40
Balance sheet total (assets)14 654.0018 316.6118 251.6322 823.4218 873.77

Equity and liabilities (kDKK)

2021
2022
2023
2024
2025
Share capital1 000.001 000.001 000.001 000.001 000.00
Other reserves230.00157.4978.74
Retained earnings3 563.003 666.865 304.496 993.898 756.71
Profit of the financial year31.001 558.891 610.651 762.83747.03
Shareholders equity total4 824.006 383.247 993.899 756.7110 503.74
Provisions311.00440.50437.44425.12359.35
Non-current loans from credit institutions614.001 568.221 119.86868.24580.97
Non-current other liabilities482.00
Non-current deferred tax liabilities491.93509.15524.94544.36
Non-current liabilities total1 096.002 060.151 629.011 393.171 125.33
Current loans from credit institutions4 891.005 585.242 783.296 040.541 656.50
Current trade creditors1 586.001 871.861 522.702 521.851 991.15
Current owed to group member70.00515.001 228.49772.67242.54
Short-term deferred tax liabilities331.50426.84493.271 070.55
Other non-interest bearing current liabilities1 876.00-7 174.462 229.981 420.091 924.61
Current liabilities total8 423.001 129.138 191.3011 248.416 885.35
Balance sheet total (liabilities)14 654.0010 013.0218 251.6322 823.4218 873.77
Page generated